ReviewMediastinum (Hong Kong, China)2025
Intraoperative complications during robotic thymectomy and their management: a narrative review.
Review in Mediastinum (Hong Kong, China), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Myasthenia Gravis and Thymoma.Muscle & nerve · 2026Review
- Robotic thymectomy in myasthenia gravis: current evidence, outcomes, and future perspective.Journal of cardiothoracic surgery · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Complete thymectomy is the established treatment for thymic epithelial tumors (TET) and often included in the management of myasthenia gravis. Minimally invasive approaches, including robotic-assisted techniques, have gained acceptance for their benefits in reducing postoperative pain and recovery time. Thymectomy poses risks due to the proximity of the thymus to critical mediastinal structures, and intraoperative complications confronted on the robotic platform can be precarious. Current literature on intraoperative complications is fragmented and limited, and lacks emphasis on the nuance brought about by the robotic platform specifically. The aim of this narrative review is to comprehensively explore such possible complications and to discuss their distinct management strategies in a systematic manner. Methods: We review the literature by examining the PubMed database between 2000 and 2024 for relevant studies that report the intraoperative and postoperative complications of robotic thymectomy. The technique of robotic thymectomy is also described. Key Content and Findings: Robotic thymectomy offers a safe and oncologically effective approach to treatment. It is met with a low complication rate that is not increased compared to the open approach. Common complications include injury to nearby structures such as the internal mammary vessels, brachiocephalic vein (BCV), superior vena cava (SVC), phrenic nerve, and recurrent laryngeal nerve. Each complication requires a distinct management strategy that is concordant with an understanding of the limitations of the robotic platform. Conclusions: This narrative review focuses on the intraoperative complications encountered during robotic thymectomy and provides an in-depth review of strategies for managing these complications, emphasizing the importance of preoperative planning, understanding the robotic platform's limitations, and the need for a well-coordinated surgical team. Reviewing the complexity of such complications and their nuanced management strategies is not only beneficial for surgeons in their clinical practice, but also to develop scientific curiosities surrounding this topic to ultimately improve patient outcomes. As such, studies elaborating on the details of such complications while on the robotic platform are necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.